Some of the mystery of autosomal dominant polycystic kidney disease (ADPKD) is starting to clear. Basic research is shedding light on its pathogenesis, and new treatments are in clinical trials. This paper reviews some of these advances and what they mean to patients.
No takes yet. Share an insight, caveat, or question.
William E. Braun (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: